Preterm birth is defined as birth before 37 weeks’ gestational age. With an incidence of 7% to 11%, it is one of the major causes of perinatal mortality and morbidity. Preterm birth is considered a clinical syndrome, which arises from different pathological processes that activate prematurely one or more components of the mechanisms leading to parturition. The premature activation of labor may be caused by multiple pathological conditions; in particular a deregulation of the immune system and an exaggeration of inflammatory processes represent common central mechanisms. The complex pathogenesis, the main risk factors and the different therapeutic options will be described in the present review. Since its incidence is still increasing in the last decades, the goal is to improve the primary and secondary prevention.
VrachnisNMalamasFMSifakisSTsikourasPIliodromitiZ.Immune aspects and myometrial actions of progesterone and CRH in labor [published online ahead of print October 19, 2011]. Clin Dev Immunol. doi:10.1155/2012/937618.
7.
ParkingtonHCColemanHA.Excitability in uterine smooth muscle. Front Horm Res. 2001;27:179–200.
8.
GarfieldREManerWLMacKayLBSchlembachDSaadeGR. Comparing uterine electromyography activity of antepartum patients versus term labor patients. Am J Obstet Gynecol2005;193(1):23–29.
9.
LeongASNormanJESmithR. Vascular and myometrial changes in the human uterus at term. Reprod Sci. 2008;15(1):59–65.
López BernalA. The regulation of uterine relaxation. Semin Cell Dev Biol. 2007;18(3):340–347.
12.
LyeSJOuC-WTeohT-GThe molecular basis of labour and tocolysis. Fetal Matern Med Rev. 1998;10(3):121–136.
13.
YuJTLopez BernalA. The cytoskeleton of human myometrial cells. J Reprod Fertil. 1998;112(1):185–198.
14.
MacpheeDJLyeSJ. Focal adhesion signaling in the rat myometrium is abruptly terminated with the onset of labor. Endocrinology. 2000;141(1):274–283.
15.
SanbornBMKuCYShlykovSBabichL. Molecular signaling through G-proteincoupled receptors and the control of intracellular calcium in myometrium. J Soc Gynecol Investig. 2005;12(7):479–487.
16.
GimplGFahrenholzF. The oxytocin receptor system: structure, function, and regulation. Physiol Rev. 2001;81(2):629–683.
17.
VieroCShibuyaIKitamuraNOxytocin: crossing the bridge between basic science and pharmacotherapy. CNS Neurosci Ther. 2010;16(5):e138–e156.
18.
SoloffMSJengYJCoplandJAStrakovaZHoareS.Signal pathways mediating oxytocin stimulation of prostaglandin synthesis in select target cells. Exp Physiol. 2000;85:51S–58S.
19.
ShlykovSGYangMAlcornJLSanbornBM. Capacitative cation entry in human myometrial cells and augmentation by hTrpC3 overexpression. Biol Reprod. 2003;69(2):647–655.
20.
MacDougallMWEurope-FinnerGNRobsonSC. Human myometrial quiescence and activation during gestation and parturition involve dramatic changes in expression and activity of particulate type II (RII alpha) protein kinase A holoenzyme. J Clin Endocrinol Metab. 2003;88(5):2194–2205.
21.
GolightlyEJabbourHNNormanJE. Endocrine immune interactions in human parturition. Mol Cell Endocrinol. 2011;335(1):52–59.
22.
BaldwinASJr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649–648.
23.
LeeYAllportVSykesALindstromTSlaterDBennettP. The effects of labour and of interleukin 1 beta upon the expression of nuclear factor kappa B related proteins in human amnion. Mol Hum Reprod. 2003;9(4):213–218.
24.
MitchellBFTaggartMJ. Are animal models relevant to key aspects of human parturition?Am J Physiol Regul Integr Comp Physiol. 2009;297(3):R525–R545.
25.
MesianoSChanECFitterJTKwekKYeoGSmithR. Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. J Clin Endocrinol Metab. 2002;87(6):2924–2930.
26.
MerlinoAAWelshTNTanHNuclear progesterone receptors in the human pregnancy myometrium: evidence that parturition involves functional progesterone withdrawal mediated by increased expression of progesterone receptor-A. J Clin Endocrinol Metab. 2007;92(5):1927–1933.
27.
Stjernholm-VladicYWangHStygarDEkmanGSahlinL. Differential regulation of the progesterone receptor A and B in the human uterine cervix at parturition. Gynecol Endocrinol. 2004;18(1):41–46.
28.
McLeanMBisitsADaviesJWoodsRLowryPSmithR. A placental clock controlling the length of human pregnancy. Nat Med. 1995;1(5):460–463.
29.
PetragliaFImperatoreAChallisJR. Neuroendocrine mechanisms in pregnancy and parturition. Endocr Rev. 2010;31(6):783–816.
30.
ZoumakisEKalantaridouSNMakrigiannakisA. CRH-like peptides in human reproduction. Curr Med Chem. 2009;16(32):4230–1235.
31.
ChallisJRGMatthewsSGGibbWLyeSJ. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev. 2000;21(5):514–550.
32.
SmithR. Parturition. N Engl J Med. 2007;356(3):271–283.
33.
MesianoSWelshTN. Steroid hormone control of myometrial contractility and parturition. Semin Cell Dev Biol. 2007;18(3):321–331.
34.
BenedettoCPetragliaFMarozioLCorticotropin-releasing hormone increases prostaglandin F2 alpha activity on human myometrium in vitro. Am J Obstet Gynecol. 1994;171(1):126–131.
35.
WeinerCPMasonCWDongYBuhimschiIASwaanPWBuhimschiCS.Human effector/initiator gene sets that regulate myometrial contractility during term and preterm labor. Am J Obstet Gynecol. 2010;202(5):474.e1–474.e20.
36.
KeelanJABlumensteinMHelliwellRJSatoTAMarvinKWMitchellMD. Cytokines, prostaglandins and parturition--a review. Placenta. 2003;24(suppl A):S33–S46.
37.
TattersallMEngineerNKhanjaniSPro-labour myometrial gene expression: are preterm labour and term labour the same?Reproduction. 2008;135(4):569–579.
38.
GoldenbergRLCulhaneJF. Pregnancy health status and the risk of preterm delivery. Arch Pediatr Adolesc Med. 2005;159(1):89–90.
39.
GoldenbergRLGoepfertARRamseyPS. Biochemical markers for the prediction of preterm birth. Am J Obstet Gynecol. 2005;192(suppl 5):36–46.
40.
GoldenbergRLCliverSPMulvihillFXMedical, psychosocial, and behavioural risk factors do not explain the increased risk for low birth weight among blackwomen. Am J Obstet Gynecol. 1996;175(5):1317–1324.
41.
NeggersYGoldenbergRCliverSHauthJ. The relationship between psychosocial profile, health practices, and pregnancy outcomes. Acta Obstet Gynecol Scand. 2006;85(3):277–285.
42.
BloomfieldFH.How is maternal nutrition related to preterm birth?Annu Rev Nutr. 2011;31:235–261.
43.
GoldenbergRLCulhaneJFJohnsonDC. Maternal infection and adverse fetal and neonatal outcomes. Clin Perinatol. 2005;32(3):523–559.
44.
GoldenbergRLAndrewsWWFaye-PetersenOCliverSGoepfertARHauthJC. The Alabama preterm birth project: placental histology in recurrent spontaneous and indicated preterm birth. Am J Obstet Gynecol. 2006;195(3):792–796.
45.
SmithGCPellJPDobbieR. Interpregnancy interval and risk of preterm birth and neonatal death: retrospective cohort study. BMJ. 2003;327(7410):313.
46.
JakobssonMGisslerMSainioSPaavonenJTapperAM. Preterm delivery after surgical treatment for cervical intraepithelial neoplasia. Obstet Gynecol. 2007;109(2 pt 1):309–313.
47.
AliyuMHLynchOSaiduRAlioAPMartyPJSalihuHM. Intrauterine exposure to tobacco and risk of medically indicated and spontaneous preterm birth. Am J Perinatol. 2010;27(5):405–410.
48.
OffenbacherSBoggessKAMurthaAPProgressive periodontal disease and risk of very preterm delivery. Obstet Gynecol. 2006;107(1):29–36.
49.
LarsenBHwangJ.Mycoplasma, Ureaplasma, and adverse pregnancy outcomes: a fresh look [published online ahead of print July 12, 2010]. Infect Dis Obstet Gynecol. doi:10.1155/2010/521921.
50.
HillierSLKrohnMACassenEEasterlingTRRabeLKEschenbachDA. The role of bacterial vaginosis and vaginal bacteria in amniotic fluid infection in women in preterm labor with intact fetal membranes. Clin Infect Dis. 1994;20(suppl 2):S276–S278.
51.
StockSNormanJ. Preterm and term labour in multiple pregnancies. Semin Fetal Neonatal Med. 2010;15(6):336–341.
52.
FoxNSJean-PierreCPredanicMChasenST. Short cervix: is a follow-up measurement useful?Ultrasound Obstet Gynecol. 2007;29(1):44–46.
53.
KrupaFGFaltinDCecattiJGSuritaFGSouzaJP. Predictors of preterm birth. Int J Gynaecol Obstet. 2006;94(1):5–11.
54.
ChallisJRLockwoodCJMyattLNormanJEStraussJF 3rd, PetragliaF. Inflammation and pregnancy. Reprod Sci. 2009;16(2):206–215.
55.
RomeroREspinozaJChaiworapongsaTKalacheK. Infection and prematurity and the role of preventive strategies. Semin Neonatol. 2002;7(4):259–274.
56.
DudleyDJCollmerDMitchellMDTrautmanMS. Inflammatory cytokine mRNA in human gestational tissues: implications for term and preterm labor. J Soc Gynecol Invest. 1996;3(6):328–335.
57.
OsmanIYoungALedinghamMALeukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term. Mol Hum Reprod. 2003;9(1):41–45.
58.
LamontRF. Setting up a preterm prevention clinic: a practical guide. BJOG. 2006;113(suppl 3):86–92.
XuPAlfaidyNChallisJR. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor. J Clin Endocrinol Metab. 2002;87(3):1353–1361.
61.
TakPPFiresteinGS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest. 2001;107(1):7–11.
62.
AckermanWE4th, SummerfieldTLVandreDDRobinsonJMKnissDA. Nuclear factor-kappa B regulates inducible prostaglandin E synthase expression in human amnion mesenchymal cells. Biol Reprod. 2008;78(1):68–76.
63.
CopperRLGoldenbergRLDasAThe preterm prediction study: maternal stress is associated with spontaneous preterm birth at less than thirty-five weeks' gestation. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 1996;175(5):1286–1292.
TorricelliMGiovannelliALeucciELabor (term and preterm) is associated with changes in the placental mRNA expression of corticotrophin-releasing factor. Reprod Sci. 2007;14(3):241–245.
66.
PetragliaFAguzzoliLFlorioPMaternal plasma and placental immunoreactive corticotrophin-releasing factor concentrations in infection associated term and pre-term delivery. Placenta. 1995;16(2):157–164.
67.
TorricelliMNovembriRBloiseEChanges in placental CRH, urocortins, and CRH-receptor mRNA expression associated with preterm delivery and chorioamnionitisJ Clin Endocrinol Metab. 2011;96(2):534–540.
68.
PetragliaFGarutiGCDe RamundoBMechanism of action of interleukin-1 beta in increasing corticotropin-releasing factor and adrenocorticotropin hormone release from cultured human placental cells. Am J Obstet Gynecol. 1990;163(4 pt 1):1307–1312.
69.
PikeIL. Maternal stress and fetal responses: evolutionary perspectives on preterm delivery. Am J Hum Biol. 2005;17(1):55–65.
70.
PetragliaFHatchMCLapinskiRLack of effect of psychosocial stress on maternal corticotropin-releasing factor and catecholamine levels at 28 weeks' gestation. J Soc Gynecol Investig. 2001;8(2):83–88.
71.
WadhwaPDCulhaneJFRauhVBarveSS. Stress and preterm birth: neuroendocrine, immune/inflammatory, and vascular mechanisms. Matern Child Health J. 2001;5(2):119–125.
72.
BoydHAPoulsenGWohlfahrtJMurrayJCFeenstraBMelbyeM. Maternal contributions to preterm delivery. Am J Epidemiol. 2009;170(11):1358–1364.
73.
HolstDGarnierY. Preterm birth and inflammation-The role of genetic polymorphisms. Eur J Obstet Gynecol Reprod Biol. 2008;141(1):3–9.
74.
MiraJPCariouAGrallFAssociation of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA. 1999;282(6):561–568.
75.
MooreSIdeMRandhawaMWalkerJJReidJGSimpsonNA. An investigation into the association among preterm birth, cytokine gene polymorphisms and periodontal disease. BJOG. 2004;111(2):125–132.
76.
CriderKSWhiteheadNBuusRM. Genetic variation associated with preterm birth: a HuGE review. Genet Med. 2005;7(9):593–604.
77.
RomeroRKusanovicJPChaiworapongsaTHassanSS. Placental bed disorders in preterm labor, preterm PROM, spontaneous abortion and abruptio placentae. Best Pract Res Clin Obstet Gynaecol. 2011;25(3):313–327.
78.
AriasFRodriquezLRayneSCKrausFT. Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol. 1993;168(2):585–591.
79.
AriasFVictoriaAChoKKrausF. Placental histology and clinical characteristics of patients with preterm premature rupture of membranes. Obstet Gynecol. 1997;89(2):265–271.
80.
BrosensIPijnenborgRVercruysseLRomeroR. The “Great Obstetrical Syndromes” are associated with disorders of deep placentation. Am J Obstet Gynecol. 2011;204(3):193–201.
81.
LalanneCMironneauCMironneauJSavineauJP. Contractions of rat uterine smooth muscle induced by acetylcholine and angiotensin II in Ca2+-free medium. Br J Pharmacol. 1984;81(2):317–326.
82.
CamposGAGuerraFAIsraelEJ. Angiotensin II induced release of prostaglandins from rat uterus. Arch Biol Med Exp (Santiago). 1983;16(1):43–49.
83.
FiskNMRonderos-DumitDTannirandornYNicoliniUTalbertDRodeckCH. Normal amniotic pressure throughout gestation. Br J Obstet Gynaecol. 1992;99(1):18–22.
84.
OuCWChenZQQiSLyeSJ. Increased expression of the rat myometrial oxytocin receptor messenger ribonucleic acid during labor requires both mechanical and hormonal signals. Biol Reprod. 1998;59(5):1055–1061.
85.
SennstromMKBraunerALuYGranstromLMMalmstromALEkmanGE. Interleukin-8 is a mediator of the final cervical ripening in humans. Eur J Obstet Gynecol Reprod Biol. 1997;74(1):89–92.
86.
RajabiMSolomonSPooleAR. Hormonal regulation of interstitial collagenase in the uterine cervix of the pregnant guinea pig. Endocrinology. 1991;128(2):863–871.
87.
DenisonFCCalderAAKellyRW. The action of prostaglandin E2 on the human cervix: stimulation of interleukin 8 and inhibition of secretory leukocyte protease inhibitor. Am J Obstet Gynecol. 1999;180(3 pt 1):614–620.
88.
EkerhovdEWeijdegardBBrannstromMMattsby-BaltzerINorstromA. Nitric oxide induced cervical ripening in the human: involvement of cyclic guanosine monophosphate, prostaglandin F(2 alpha), and prostaglandin E(2). Am J Obstet Gynecol. 2002;186(4):745–750.
89.
IamsJDGoldenbergRLMeisPJThe length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N Engl J Med. 1996;334(9):567–572.
90.
RackowBWAriciA. Reproductive performance of women with müllerian anomalies. Curr Opin Obstet Gynecol. 2007;19(3):229–237.
91.
HassanSRomeroRHendlerIA sonographic short cervix as the only clinical manifestation of intra-amniotic infection. J Perinat Med. 2006;34(1):13–19.
92.
MenonRTorloniMRVoltoliniCBiomarkers of spontaneous preterm birth: an overview of the literature in the last four decades. Reprod Sci. 2011;18(11):1046–1070.
93.
Conde-AgudeloAPapageorghiouATKennedySHVillarJ. Novel biomarkers for the prediction of the spontaneous preterm birth phenotype: a systematic review and meta-analysis. BJOG. 2011;118(9):1042–1054.
94.
GoldenbergRLIamsJDMercerBMMaternal-Fetal Medicine Units Network. The preterm prediction study: toward a multiple-marker test for spontaneous preterm birth. Am J Obstet Gynecol. 2001;185(3):643–651.
95.
GoepfertARGoldenbergRLAndrewsWWThe preterm prediction study: association between cervical interleukin 6 concentration and spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 2001;184(3):483–488.
96.
ColemanMAKeelanJAMcCowanLMTownendKMMitchellMD. Predicting preterm delivery: comparison of cervicovaginal interleukin (IL)-1beta, IL-6 and IL-8 with fetal fibronectin and cervical dilatation. Eur J Obstet Gynecol Reprod Biol. 2001;95(2):154–158.
97.
GervasiMTRomeroRBracalenteGMidtrimester amniotic fluid concentrations of interleukin-6 and interferon-gamma-inducible protein-10: evidence for heterogeneity of intra-amniotic inflammation and associations with spontaneous early <32 weeks) and late >32 weeks) preterm delivery. J Perinat Med. 2012;40(4):329–343.
98.
PetragliaFFlorioPNappiCGenazzaniAR. Peptide signaling in human placenta and membranes: autocrine, paracrine, and endocrine mechanisms. Endocr Rev. 1996;17(2):156–186.
99.
McGregorJAJacksonGMLachelinGCSalivary estriol as risk assessment for preterm labor: a prospective trial. Am J Obstet Gynecol. 1995;173(4):1337–1342.
100.
GoodwinTM. A role for estriol in human labor, term and preterm. Am J Obstet Gynecol. 1999;180(1 pt 3): S208–S213.
101.
HeineRPMcGregorJAGoodwinTMSerial salivary estriol to detect an increased risk of preterm birth. Obstet Gynecol. 2000;96(4):490–497.
102.
SmithRSmithJIShenXPatterns of plasma corticotropin-releasing hormone, progesterone, estradiol, and estriol change and the onset of human labor. J Clin Endocrinol Metab. 2009;94(6):2066–2074.
103.
FarinaALambert-MesserlianGMCanickJATotal activin A in maternal blood as a marker of preterm delivery in low-risk asymptomatic patients. Prenat Diagn. 2006;26(3):277–281.
104.
LockwoodCJ. The diagnosis of preterm labor and the prediction of preterm delivery. Clin Obstet Gynecol. 1995;38(4):675–687.
105.
KorebritsCRamirezMMWatsonLBrinkmanEBockingADChallisJR. Maternal corticotropin-releasing hormone is increased with impending preterm birth. J Clin Endocrinol Metab. 1998;83(5):1585–1591.
106.
FlorioPLintonEATorricelliMPrediction of preterm delivery based on maternal plasma urocortin. J Clin Endocrinol Metab. 2007;92(12):4734–4737.
107.
ChandiramaniMDi RenzoGCGottschalkEFetal fibronectin as a predictor of spontaneous preterm birth: a European perspective. J Matern Fetal Neonatal Med. 2011;24(2):330–336.
108.
CooperSLangeIWoodSTangSMillerLRossS. Diagnostic accuracy of rapid phIGFBP-I assay for predicting preterm labor in symptomatic patients. J Perinatol. 2012;32(6):460–465.
109.
DeFrancoETeramoKMugliaL. Genetic influences on preterm birth. Semin Reprod Med. 2007;25(1):40–51.
110.
PapazoglouDGalaziosGKoukourakisMIKontomanolisENMaltezosE. Association of -634G/C and 936C/T polymorphisms of the vascular endothelial growth factor with spontaneous preterm delivery. Acta Obstet Gynecol Scand. 2004;83(5):461–465.
111.
GibsonCSMacLennanAHJanssenNGAssociations between fetal inherited thrombophilia and adverse pregnancy outcomes. Am J Obstet Gynecol. 2006;194(4):947 e1–e10.
112.
HaoKWangXNiuTA candidate gene association study on preterm delivery: application of high-throughput genotyping technology and advanced statistical methods. Hum Mol Genet. 2004;13(7):683–691.
113.
HartelCvon OtteSKochJPolymorphisms of haemostasis genes as risk factors for preterm delivery. Thromb Haemost. 2005;94(1):88–92.
114.
LorenzEHallmanMMarttilaRHaatajaRSchwartzDA. Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population. Pediatr Res. 2002;52(3):373–376.
115.
LandauRXieHG, Dishy V, et al. beta2-Adrenergic receptor genotype and preterm delivery. Am J Obstet Gynecol. 2002;187(5):1294–1298.
116.
OzkurMDoguluFOzkurAGokmenBInalozSSAynaciogluAS. Association of the Gln27Glu polymorphism of the beta-2-adrenergic receptor with preterm labor. Int J Gynaecol Obstet. 2002;77(3):209–215.
117.
ChenDHuYChenCPolymorphisms of the paraoxonase gene and risk of preterm delivery. Epidemiology. 2004;15(4):466–470.
118.
FerrandPEParrySSammelMA polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol Hum Reprod. 2002;8(5):494–501.
119.
RomeroRChaiworapongsaTEspinozaJFetal plasma MMP-9 concentrations are elevated in preterm premature rupture of the membranes. Am J Obstet Gynecol. 2002;187(5):1125–1130.
120.
WangHParrySMaconesGFunctionally significant SNP MMP8 promoter haplotypes and preterm premature rupture of membranes PPROM). Hum Mol Genet. 2004;13(21):2659–2669.
121.
RCOG.Antenatal Corticosteroids to Reduce Neonatal Morbidity and Mortality. Green-top Guideline No. 7; 2010.
122.
PeyronRAubényETargoszVEarly termination of pregnancy with mifepristone RU 486) and the orally active prostaglandin misoprostol. N Engl J Med. 1993;328(21):1509–1513.
123.
AllportVCPieberDSlaterDMNewtonRWhiteJOBennettPR. Human labour is associated with nuclear factor-kappaB activity which mediates cyclo-oxygenase-2 expression and is involved with the `functional progesterone withdrawal'. Mol Hum Reprod. 2001;7:581–586.
124.
PeltierMRTeeSCSmulianJC. Effect of progesterone on proinflammatory cytokine production by monocytes stimulated with pathogens associated with preterm birth. Am J Reprod Immunol. 2008;60(4):346–353.
125.
ShieldsADWrightJPaonessaDJProgesterone modulation of inflammatory cytokine production in a fetoplacental artery explant model. Am J Obstet Gynecol. 2005;193(3 pt 2):1144–1148.
126.
NorwitzERRobinsonJNChallisJRG. The control of labor. N Engl J Med. 1999;341(9):660–666.
MesianoSWangYNorwitzER. Progesterone receptors in the human pregnancy uterus: do they hold the key to birth timing?Reprod Sci. 2011;18(1):6–19.
129.
CondonJCJeyasuriaPFaustJMWilsonJWMendelsonCR. A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition. Proc Natl Acad Sci U S A. 2003;100(16):9518–9523.
130.
NorwitzERCaugheyAB. Progesterone supplementation and the prevention of preterm birth. Rev Obstet Gynecol. 2011;4(2):60–72.
131.
Society for Maternal-Fetal Medicine Publications Committee, with assistance of Vincenzo Berghella. Progesterone and preterm birth prevention: translating clinical trials data into clinical practice. Am J Obstet Gynecol. 2012;206(5):376–386.
132.
RomeroRNicolaidesKConde-AgudeloAVaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol. 2012;206(2):124.e1–124.e19.
133.
RozenbergPChauveaudADeruellePPrevention of preterm delivery after successful tocolysis in preterm labor by 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial. Am J Obstet Gynecol. 2012;206(3):206.e1–206.e9.
134.
DurnwaldCPMomirovaVRouseDJSecond trimester cervical length and risk of preterm birth in women with twin gestations treated with 17-α hydroxyprogesterone caproate. J Matern Fetal Neonatal Med. 2010;23(12):1360–1364.
135.
CrossRG.Treatment of habitual abortion due to cervical incompetence. Lancet. 1959;274(7094):127.
136.
GoyaMPratcoronaLMercedCCervical pessary in pregnant women with a short cervix PECEP): an open-label randomised controlled trial. Lancet. 2012;379(9828):1800–1806.
137.
HassanSSRomeroRBerryMaymon EDoes cervical cerclage prevent preterm delivery in patients with a short cervix?Am J Obstet Gynecol. 2001;184(7):1325–1329.
138.
BerghellaVKeelerSMToMSAlthuisiusSMRustOA. Effectiveness of cerclage according to severity of cervical length shortening: a meta-analysis. Ultrasound Obstet Gynecol. 2010;35(4):468–473.
139.
BerghellaVOdiboAOToMSRustOAAlthuisiusSM. Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data. Obstet Gynecol. 2005;106(1):181–189.
140.
American College of Obstetricians and Gynecologists; Committee on Practice Bulletins—Obstetrics. ACOG practice bulletin no. 127: Management of preterm labor. Obstet Gynecol. 2012;119(6):1308–1317.
141.
RCOG Tocolysis for Women in Preterm Labour. Green-top GuidelineNo. 1b.
142.
GreenfieldPJLamontRF.The contemporary use of tocolytics. Current Obstet Gynaecol. 2000;10(4):218–224.
143.
GoldenbergRLCliverSPBronsteinJCutterGRAndrewsWWMennemeyerST. Bed rest in pregnancy. Obstet Gynecol. 1994;84(1):131–136.
144.
TanTCDevendraKTanLKTanHK. Tocolytic treatment for the management of preterm labour: a systematic review. Singapore Med J. 2006;47(5):361–366.
145.
AnotayanonthSSubhedarNVGarnerPNeilsonJPHarigopalS.Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev. 2004;(4):CD004352.
146.
CaritisSNChiaoJPKridgenP. Comparison of pulsatile and continuous ritodrine administration: effects on uterine contractility and beta-adrenergic receptor cascade. Am J Obstet Gynecol. 1991;164(4):1005–1011.
147.
The Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med. 1992;327(5):308–312.
148.
U.S. Food and Drug Administration. FDA drug safety communication: new warnings against use of terbutaline to treat preterm labor. Silver Spring MD): FDA; 2011. http://www.fda.gov/drugs/drugsafety/ucm243539.htm. Accessed March 20, 2012. Level III)
149.
WitterFRZimmermanAWReichmannJPConnorsSL.In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes. Am J Obstet Gynecol. 2009;201(6):553–559.
150.
SmithGN. What are the realistic expectations of tocolytics?BJOG. 2003;110(suppl 20):103–106.
151.
MelinP.Development of an oxytocin antagonist atosiban. Res Clin Forums. 1994;16(3):155–168.
MoutquinJMShermanDCohenHDouble-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am J Obstet Gynecol. 2000;182(5):1191–1199.
154.
ValenzuelaGJSanchez-RamosLRomeroRMaintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group. Am J Obstet Gynecol. 2000;182(5):1184–1190.
155.
SanbornBM. Ion channels and the control of myometrial electrical activity. Semin Perinatol. 1995;19(1):31–40.
156.
BleaCWBarnardJMMagnessRREffect of nifedipine on fetal and maternal hemodynamics and blood gases in the pregnant ewe. Am J Obstet Gynecol. 1997;176(4):922–930.
157.
RichSKaufmannELevyPS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. An Engl J Med. 1992;327(2):76–81.
158.
PapatsonisDNKokJHvan GeijnHPBlekerOPAdèrHJDekkerGA. Neonatal effects of nifedipine and ritodrine for preterm labour. Obs Gynecol. 2000;95(4):477–486.
159.
DoretMMellierGBenchaibMPiacenzaJMGharibCPasquierJC.In vitro study of tocolytic effect of rofecoxib, a specific cyclo-oxygenase 2 inhibitor. Comparison and combination with other tocolytic agents. BJOG. 2002;109(9):983–988.
160.
PapatsonisDNVan GeijnHPAdèrHJLangeFMBlekerOPDekkerGA. Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial. Obstet Gynecol. 1997;90(2):230–234.
161.
MoiseKJHuhtaJCSharifDSIndomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus. N Engl J Med. 1988;319(6):327–331.
162.
EronenMPesonenEKurkiTTeramoKYlikorkalaOHallmanM. Increased incidence of bronchopulmonary dysplasia after antenatal administration of indomethacin to prevent preterm labor. J Pediatr. 1994;124(5 pt 1):782–788.
163.
NortonMEMerrillJCooperBAKullerJAClymanRI. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med. 1993;329(22):1602–1607.
164.
SouterDHardingJMcCowanLO'DonnellCMcLeayEBaxendaleH. Antenatal indomethacin--adverse fetal effects confirmed. Aust N Z J Obstet Gynaecol. 1998;38(1):11–16.
165.
VermillionSTScardoJALashusAGWilesHB. The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age. Am J Obstet Gynecol. 1997;177(2):256–259.
166.
OlsonDMAmmannC.Role of the prostaglandins in labour and prostaglandin receptor inhibitors in the prevention of preterm labour. Front Biosci. January 2007;12:1329–1343.
167.
ACOG Committee on Practice Bulletins--Obstetrics. ACOG practice bulletin. Management of preterm labor. Number 43, May 2003. Int J Gynaecol Obstet. 2003;82(1):127–135.
168.
MercerBM, Merlino AA Magnesium sulfate for preterm labor and preterm birth. Obstet Gynecol. 2009;114(3):650–668.
169.
PanethNJettonJPinto-MartinJSusserM.Magnesium sulfate in labor and risk of neonatal brain lesions and cerebral palsy in low birth weight infants. The Neonatal Brain Hemorrhage Study Analysis Group. Pediatrics. 1997;99(5):E1.
170.
MarretSMarpeauLZupan-SimunekVMagnesium sulphate given before very-preterm birth to protect infant brain: the randomized controlled PREMAG trial. PREMAG trial group. BJOG. 2007;114(3):310–318.
171.
RouseDJHirtzDGThomEA randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med. 2008;359(9):895–905.
172.
GoldenbergRL. The management of preterm labor. Obstet Gynecol. 2002;100(5 pt 1):1020–1037.
173.
SosaCAlthabeFBelizanJMBergelE.Bed rest in singleton pregnancies for preventing preterm birth. Cochrane Database Syst Rev. 2004;(1):CD003581.
174.
MaloniJA. Antepartum bed rest for pregnancy complications: efficacy and safety for preventing preterm birth. Biol Res Nurs. 2010;12(2):106–124.
175.
SubramaniamAAbramoviciAAndrewsWWTitaAT.Antimicrobials for preterm birth prevention: an overview [published ahead of print February 25, 2012]. Infect Dis Obstet Gynecol. doi:10.1155/2012/157159.
ACOG Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 80: premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol. 2007;109(4):1007–1019.
178.
American College of Obstetricians and Gynecologists Committee on Obstetric Practice. ACOG Committee Opinion No. 485: prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol. 2011;117(4):1019–1027.
179.
MerensteinGBWeismanLE. Premature rupture of the membranes: neonatal consequences. Semin Perinatol. 1996;20(5):375–380.
KingJFlenadyV.Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane Database Syst Rev. 2002;(4):CD000246.
182.
KenyonSBoulvainMNeilsonJP.Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev. 2010;(4):CD001058.
183.
MercerB. Antibiotics in the management of PROM and preterm labor. Obstet Gynecol Clin North Am. 2012;39(1):65–76.
184.
BerkmanNDThorpJMJr, HartmannKEManagement of preterm labor. Evidence Report/Technology Assessment No. 18 Prepared by Research Triangle Institute under Contract No. 290-97-0011). AHRQ Publication No. 01-E021. Rockville MD): Agency for Healthcare Research and Quality; 2000. (Level III)
185.
RobertsDDalzielSR.Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Syst Rev. 2006;(3):CD004454.
LeitichH.Secondary predictors of preterm labour. BJOG. 2005 Mar;112suppl 1:48–50.
190.
LeeHJParkTCNorwitzER. Management of pregnancies with cervical shortening: a very short cervix is a very big problem. Rev Obstet Gynecol. 2009;2(2):107–115.
191.
ClementSCandyBHeathVToMNicolaidesKH. Transvaginal ultrasound in pregnancy: its acceptability to women and maternal psychological morbidity. Ultrasound Obstet Gynecol. 2003;22(5):508–514.
192.
OkitsuOMimuraTNakayamaTAonoT. Early prediction of preterm delivery by transvaginal ultrasonography. Ultrasound Obstet Gynecol. 1992;2(6):402–409.
193.
CarlanSJRichmondLBO’BrienWF. Randomized trial of endovaginal ultrasound in preterm premature rupture of membranes. Obstet Gynecol. 1997;89(3):458–461.
194.
Krebs-JimenezJNeubertAG. The microbiological effects of endovaginal sonographic assessment of cervical length. J Ultrasound Med. 2002;21(7):727–729.
195.
GramelliniDFieniSMolinaEBerrettaRVadoraE.Transvaginal sonographic cervical length changes during normal pregnancy. J Ultrasound Med. 2002;21(3):227–232.
196.
BerghellaVOwenJMacPhersonCNatural history of cervical funneling in women at high risk for spontaneous preterm birth. Obstet Gynecol. 2007;109(4):863–869.
197.
AndrewsWWCopperRHauthJCGoldenbergRLNeelyCDubardM. Secondtrimester cervical ultrasound: associations with increased risk for recurrent early spontaneous delivery. Obstet Gynecol. 2000;95(2):222–226.
198.
OwenJIamsJDHauthJC. Vaginal sonography and cervical incompetence. Am J Obstet Gynecol. 2003;188(2):586–596.
199.
OwenJYostNBerghellaVMid-trimester endovaginal sonography in women at high risk for spontaneous preterm birth. JAMA. 2001;286(11):1340–1348.
200.
BerghellaVBaxterJKHendrixNW.Cervical assessment by ultrasound for preventing preterm delivery. Cochrane Database Syst Rev. 2009;(3):CD007235.
201.
IamsJD. Prediction and early detection of preterm labor. Obstet Gynecol. 2003;101(2):402–412.
202.
ToMSSkentouCLiaoAWCachoANicolaidesKH. Cervical length and funneling at 23 weeks of gestation in the prediction of spontaneous early preterm delivery. Ultrasound Obstet Gynecol. 2001;18(3):200–203.
203.
VisintineJBerghellaVHenningDBaxterJ. Cervical length for prediction of preterm birth in women with multiple prior induced abortions. Ultrasound Obstet Gynecol. 2008;31(2):198–200.
204.
RomeroRKusanovicJPEspinozaJWhat is amniotic fluid `sludge'?Ultrasound Obstet Gynecol. 2007;30(5):793–798.
205.
RomeroRSchaudinnCKusanovicJPDetection of a microbial biofilm in intraamniotic infection. Am J Obstet Gynecol. 2008;198(1):135 e1–135 e50.
206.
EspinozaJGonçalvesLFRomeroRThe prevalence and clinical significance of amniotic fluid `sludge' in patients with preterm labor and intact membranes. Ultrasound Obstet Gynecol. 2005;25(4):346–352.
207.
KusanovicJPEspinozaJRomeroRClinical significance of the presence of amniotic fluid `sludge' in asymptomatic patients at high risk for spontaneous preterm delivery. Ultrasound Obstet Gynecol. 2007;30(5):706–714.
208.
BujoldEPasquierJCSimoneauJIntra-amniotic sludge, short cervix, and risk of preterm delivery. J Obstet Gynaecol Can. 2006;28(3):198–202.
209.
GauthierSTétuAHimayaEThe origin of Fusobacterium nucleatum involved in intra-amniotic infection and preterm birth. J Matern Fetal Neonatal Med. 2011;24(11):1329–1332.
210.
KusanovicJPEspinozaJRomeroRClinical significance of the presence of amniotic fluid ‘sludge’ in asymptomatic patients at high risk for spontaneous preterm delivery. Ultrasound Obstet Gynecol. 2007;30:706–714.
211.
MorencyAMBujoldE. The effect of second-trimester antibiotic therapy on the rate of preterm birth. J Obstet Gynaecol Can. 2007;29(1):35–44.
212.
MorencyAMRalluFLaferrièreCBujoldgE. Eradication of intra-amniotic Streptococcus mutans in a woman with a short cervix. J Obstet Gynaecol Can. 2006;28(10):898–902.
213.
SchmitzTMaillardFBessard-BacquaertSSelective use of fetal fibronectin detection after cervical length measurement to predict spontaneous preterm delivery in women with preterm labor. Am J Obstet Gynecol. 2006;194(1):138–143.
